NFE2L2 and metabolic syndrome: In high fructose-feeding diet mice, apigenin inhibits the binding of KEAP1 with NRF2, enhances the accumulation and nuclear translocation of NRF2 and its downstream targets HO-1 and NQO1, and ultimately prevents metabolic syndrome [76].